The European Union is suing AstraZeneca over shortfalls in the deliveries of its COVID-19 vaccine
Earlier today, the European Union confirmed that it’s taking legal action against the British - Swiss pharma company, AstraZeneca.
The EU’s action came after, in March, the European Commission President Ursula von der Leyen expressed her disappointment with the company. According to her statement, “AstraZeneca has unfortunately under-produced and under-delivered. And this painfully, of course, reduced the speed of the vaccination campaign.” So far this year, the EU and AstraZeneca have been at odds multiple times. The drug company announced that it wouldn’t deliver as many vaccines as the bloc was counting on, both during the first and the second quarter.
In the first three months of the year, the bloc expected 120 million doses but received only about 30 million. For Q2, it was hoping 70 million doses, down from 180 million originally anticipated.
According to AstraZeneca CEO Pascal Soriot, the low yields at the EU production plants were causing the delays. It has caused a postponement of vaccine’s rollouts in 27 European countries.
Later this week, all eyes will be again on the pharma company due to report quarterly figures on Friday.
Read more about the upcoming earnings reports here!
Sources: cnbc.com, finance.yahoo.com
Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.
Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.